Detail Information of Post-Translational Modifications
N-glycosylation |
|||||
---|---|---|---|---|---|
Asparagine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLCO2B1 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Asparagine |
Modified Location |
176 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
N-linked Glycosylation at SLCO2B1 Asparagine 176 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLCO2B1 | [1] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Asparagine |
Modified Location |
538 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
N-linked Glycosylation at SLCO2B1 Asparagine 538 has the potential to affect its expression or activity. | ||||
Cysteine |
10 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Impairing the function of SLCO2B1 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Cysteine |
Modified Location |
489 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 489 (i.e. Cysteine to Alanine mutation) have been reported to impaire its transport function. | ||||
PTM Phenomenon 2 |
Impairing the function of SLCO2B1 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Cysteine |
Modified Location |
495 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 495 (i.e. Cysteine to Alanine mutation) have been reported to impaire its transport function. | ||||
PTM Phenomenon 3 |
Impairing the function of SLCO2B1 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Cysteine |
Modified Location |
504 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 504 (i.e. Cysteine to Alanine mutation) have been reported to impaire its transport function. | ||||
PTM Phenomenon 4 |
Impairing the function of SLCO2B1 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Cysteine |
Modified Location |
516 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 516 (i.e. Cysteine to Alanine mutation) have been reported to impaire its transport function. | ||||
PTM Phenomenon 5 |
Impairing the function of SLCO2B1 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Cysteine |
Modified Location |
520 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 520 (i.e. Cysteine to Alanine mutation) have been reported to impaire its transport function. | ||||
PTM Phenomenon 6 |
Impairing the function of SLCO2B1 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Cysteine |
Modified Location |
539 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 539 (i.e. Cysteine to Alanine mutation) have been reported to impaire its transport function. | ||||
PTM Phenomenon 7 |
Impairing the function of SLCO2B1 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Cysteine |
Modified Location |
541 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 541 (i.e. Cysteine to Alanine mutation) have been reported to impaire its transport function. | ||||
PTM Phenomenon 8 |
Impairing the function of SLCO2B1 | [2] | |||
Role of PTM |
Protein Activity Modulation | ||||
Modified Residue |
Cysteine |
Modified Location |
553 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 553 (i.e. Cysteine to Alanine mutation) have been reported to impaire its transport function. | ||||
PTM Phenomenon 9 |
Decreasing the membrane localization and transport function of the SLCO2B1 | [2] | |||
Role of PTM |
Trafficking to Plasma Membrane | ||||
Affected Drug/Substrate |
Estrone-3-sulfate and Dehydroepiandrosterone sulfate |
Results for Drug |
Decreasing the transport of estrone-3-sulfate and dehydroepiandrosterone sulfate | ||
Modified Residue |
Cysteine |
Modified Location |
493 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 493 (i.e. Cysteine to Alanine mutation) have been reported to decrease its membrane localization and transport function. | ||||
PTM Phenomenon 10 |
Decreasing the membrane localization and transport function of the SLCO2B1 | [2] | |||
Role of PTM |
Trafficking to Plasma Membrane | ||||
Affected Drug/Substrate |
Estrone-3-sulfate and Dehydroepiandrosterone sulfate |
Results for Drug |
Decreasing the transport of estrone-3-sulfate and dehydroepiandrosterone sulfate | ||
Modified Residue |
Cysteine |
Modified Location |
557 | ||
Modified State |
Cysteine to Alanine mutation | ||||
Experimental Material(s) |
Chinese hamster ovary subclone (CHO-K1) cells | ||||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Removal of the Glycosylation at SLCO2B1 Cysteine 557 (i.e. Cysteine to Alanine mutation) have been reported to decrease its membrane localization and transport function. | ||||
Phosphorylation |
|||||
Serine |
6 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLCO2B1 | [3] , [4] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
34 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Serine 34 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLCO2B1 | [5] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
264 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Serine 264 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 3 |
Have the potential to influence SLCO2B1 | [6] , [7] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
320 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Serine 320 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 4 |
Have the potential to influence SLCO2B1 | [8] , [9] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
333 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Serine 333 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 5 |
Have the potential to influence SLCO2B1 | [10] , [11] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
687 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Serine 687 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 6 |
Have the potential to influence SLCO2B1 | [10] , [11] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Serine |
Modified Location |
688 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Serine 688 has the potential to affect its expression or activity. | ||||
Threonine |
2 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLCO2B1 | [12] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
133 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Threonine 133 has the potential to affect its expression or activity. | ||||
PTM Phenomenon 2 |
Have the potential to influence SLCO2B1 | [6] , [13] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Threonine |
Modified Location |
318 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Threonine 318 has the potential to affect its expression or activity. | ||||
Tyrosine |
1 PTM Phenomena Related to This Residue | Click to Show/Hide the Full List | |||
PTM Phenomenon 1 |
Have the potential to influence SLCO2B1 | [14] | |||
Role of PTM |
Potential impacts | ||||
Modified Residue |
Tyrosine |
Modified Location |
144 | ||
Experimental Method |
Co-Immunoprecipitation | ||||
Detailed Description |
Phosphorylation at SLCO2B1 Tyrosine 144 has the potential to affect its expression or activity. | ||||
If you find any error in data or bug in web service, please kindly report it to Dr. Yin and Dr. Li.